Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

A Text Messaging Program for Smokers in Primary Care

Phase 4

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: Brief advice
Drug: Mailed nicotine replacement therapy
Behavioral: Text messaging

First Posted Date: 2017-06-02

Last Posted Date: 2020-02-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 153

Registration Number: NCT03174158

Locations: 🇺🇸
Massacusetts General Hospital, Boston, Massachusetts, United States

Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Drug: Placebo
Drug: Inosine

First Posted Date: 2017-05-30

Last Posted Date: 2021-02-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 48

Registration Number: NCT03168711

Locations: 🇺🇸
Holy Cross Hospital, Fort Lauderdale, Florida, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

SHIFT: Studying HIV Immunology After Fecal Transplant

Phase 1

Withdrawn

Conditions: HIV/AIDS
Inflammation
Dysbiosis

Interventions: Biological: Fecal Inoculum Capsule
Biological: Placebo (for Fecal Inoculum Capsule)
Drug: Antibiotic Placebo
Drug: Antibiotic

First Posted Date: 2017-05-23

Last Posted Date: 2018-11-15

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT03163784

A Psychological-behavioral Intervention to Increase Activity in Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Behavioral: Positive Psychology + Motivational Interviewing
Behavioral: Diabetes Education

First Posted Date: 2017-05-23

Last Posted Date: 2021-02-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 70

Registration Number: NCT03164538

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Bone Mass Accrual in Children With Autism Spectrum Disorder

Completed

Conditions: Bone Diseases, Developmental
Autism Spectrum Disorder

First Posted Date: 2017-05-22

Last Posted Date: 2017-05-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 49

Registration Number: NCT03162445

Motivation-Audit-Positive Psychology Intervention Study

Completed

Conditions: Metabolic Syndrome

First Posted Date: 2017-05-19

Last Posted Date: 2019-08-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 24

Registration Number: NCT03160755

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response

Not Applicable

Active, not recruiting

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Radiation: MRI

First Posted Date: 2017-05-15

Last Posted Date: 2022-09-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT03153488

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Psychological-behavioral Intervention for Physical Activity in Type 2 Diabetes

Not Applicable

Completed

Conditions: Type2 Diabetes

Interventions: Behavioral: Positive Psychology + Motivational Interviewing
Behavioral: MI-based Health Education Intervention

First Posted Date: 2017-05-12

Last Posted Date: 2020-05-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT03150199

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)

Phase 4

Completed

Conditions: Depression

Interventions: Drug: Brexpiprazole
Drug: Placebo
Drug: Ketamine

First Posted Date: 2017-05-11

Last Posted Date: 2020-07-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 51

Registration Number: NCT03149991

Locations: 🇺🇸
Massachusetts General Hospital, Depression Clinical and Research Program, Boston, Massachusetts, United States
🇺🇸
Nathan Kline Institute for Psychiatric Research, Orangeburg, New York, United States
🇺🇸
Pacific Research Partners, LLC, Oakland, California, United States

and more 3 locations

Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma

Phase 2

Active, not recruiting

Conditions: Metastatic Melanoma

Interventions: Drug: Pembrolizumab
Drug: Dabrafenib
Drug: Trametinib

First Posted Date: 2017-05-11

Last Posted Date: 2024-03-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 16

Registration Number: NCT03149029

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts general Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy